Sign In
Buy ARAY
$0.370
-0.0286 (-7.18%)
At Close: Jun 03, 2026
Accuray (ARAY) Reports Q4 Loss, Tops Revenue Estimates
07:23pm, Wednesday, 11'th Aug 2021
Accuray (ARAY) delivered earnings and revenue surprises of 0.00% and 9.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Accuray (ARAY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
04:48pm, Wednesday, 04'th Aug 2021
Accuray (ARAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SUNNYVALE, Calif., July 22, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the medical care team at Hong Kong Sanatorium & Hospital (HKSH) in Hong Kong treated the fir
Beloved Family Pet's Lung Cancer is Treated with Targeted Radiotherapy Using the Accuray Radixact® System with Synchrony® Technology
07:30am, Thursday, 24'th Jun 2021
SUNNYVALE, Calif., June 24, 2021 /PRNewswire/ -- The University of Wisconsin-Madison (UW-Madison) School of Veterinary Medicine team is advancing cancer care as the first to treat an animal using the
Accuray Announces Promotion of Suzanne Winter to President
05:00pm, Tuesday, 22'nd Jun 2021
SUNNYVALE, Calif., June 22, 2021 /PRNewswire/ -- Accuray (NASDAQ: ARAY) announced today that Suzanne Winter has been promoted to president, effective as of July 1, 2021.
Accuray's (ARAY) CyberKnife Gets Support From RayStation TPS
08:17am, Friday, 18'th Jun 2021
Accuray (ARAY) introduces RayStation treatment planning support for CyberKnife Radiotherapy System and other radiation therapy devices.
Accuray Expands CyberKnife® System Versatility with Integration of RaySearch's RayStation Treatment Planning System
07:30am, Wednesday, 16'th Jun 2021
SUNNYVALE, Calif., June 16, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the launch of RayStation* treatment planning support for the company's CyberKnife® M6™** and S7
Accuray (ARAY) Expands Commercialization of CE-Marked ClearRT
11:17am, Monday, 14'th Jun 2021
Accuray's (ARAY) ClearRT imaging capability, which is now widely available following receipt of the CE Mark, offers better precision and accuracy in radiation therapy.
Accuray Expands Commercialization of ClearRT™ Helical Fan-Beam kVCT Imaging for the Radixact® System with CE Mark Certification
07:30am, Thursday, 10'th Jun 2021
SUNNYVALE, Calif., June 10, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company has received CE Mark certification for its ClearRT™ helical fan-beam kVCT imaging ca
More 'Hurry Up And Wait' For Accuray, But The China Opportunity Is Coming Through
04:43am, Tuesday, 08'th Jun 2021
Accuray's fiscal third quarter was a little better than expected, but the lack of strong order momentum and/or upgraded guidance from management has tempered investor enthusiasm.
Accuray (ARAY) Down 13.1% Since Last Earnings Report: Can It Rebound?
12:02pm, Thursday, 27'th May 2021
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock?
Here's Why You Should Retain Accuray (ARAY) Stock for Now
10:31am, Tuesday, 25'th May 2021
Investors continue to be optimistic about Accuray (ARAY) owing to its slew of regulatory approvals and strength in its TomoTherapy platform.
Accuray Announces New $120 Million Credit Facility
10:52pm, Thursday, 06'th May 2021
SUNNYVALE, Calif., May 6, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced it has entered into a new five-year $80 million term loan and $40 million revolving credit facilit
Accuray Announces Convertible Notes Exchange and Subscription
10:48pm, Thursday, 06'th May 2021
SUNNYVALE, Calif., May 6, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that it has entered into privately negotiated agreements with the holders of its existing 3.75% sen
Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules
04:10pm, Thursday, 06'th May 2021
SUNNYVALE, Calif., May 6, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Jean-Philippe Pignol, M.D.
